{"entity":{"id":"institut-bergonie","kind":"institution","name":"Institut Bergonié","aka":["Bergonié","Centre Régional de Lutte Contre le Cancer de Bordeaux"],"tldr":"Bordeaux's dedicated cancer hospital, a UNICANCER centre known for sarcoma, early-phase trials and precision medicine.","summary":"Founded in 1923 and named after the radiobiologist Jean Bergonié, the Institut Bergonié is the UNICANCER comprehensive cancer centre for Nouvelle-Aquitaine. It is a national reference centre for sarcomas within the French Sarcoma Group and NetSarc network, and runs an early-phase trials unit that is part of INCa's CLIP² network. Research with Université de Bordeaux and Inserm covers sarcoma biology, tumour genomics and radiotherapy. Patients can access phase 1 trials, molecular tumour boards, reconstructive surgery and supportive care on one site.","asOf":"2026-09-09","links":[{"label":"Homepage","url":"https://www.bergonie.fr"},{"label":"UNICANCER","url":"https://www.unicancer.fr"}],"tags":[],"related":[],"cancers":["sarcoma","breast-hr-positive","ovarian"],"sections":["targeted-therapy","surgery"],"technologies":["cgp","imrt-igrt","brachytherapy"],"targets":[],"drugs":[],"companies":["unicancer"],"institutions":["inca"],"pathways":[],"terms":[],"trials":[],"people":["nicolas-penel"],"bottlenecks":["b-rare-cancers"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Bordeaux","country":"FR","lat":44.833,"lng":-0.59,"institutionType":"cancer-center","website":"https://www.bergonie.fr","university":"Université de Bordeaux","programs":["Sarcoma reference centre","Early-phase trials (CLIP²)","Precision medicine","Radiotherapy"]},"route":"/institutions/institut-bergonie/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"}],"section":[{"id":"surgery","kind":"section","name":"Surgery & Interventional","route":"/fronts/surgery/"},{"id":"targeted-therapy","kind":"section","name":"Targeted Therapy","route":"/fronts/targeted-therapy/"}],"technology":[{"id":"brachytherapy","kind":"technology","name":"Brachytherapy","route":"/technologies/brachytherapy/"},{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"},{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"}],"company":[{"id":"unicancer","kind":"company","name":"UNICANCER","route":"/companies/unicancer/"}],"institution":[{"id":"inca","kind":"institution","name":"Institut National du Cancer","route":"/institutions/inca/"}],"person":[{"id":"antoine-italiano","kind":"person","name":"Antoine Italiano","route":"/people/antoine-italiano/"},{"id":"nicolas-penel","kind":"person","name":"Nicolas Penel","route":"/people/nicolas-penel/"}],"bottleneck":[{"id":"b-rare-cancers","kind":"bottleneck","name":"Rare and paediatric cancers without markets","route":"/bottlenecks/b-rare-cancers/"}]}}